Cargando…
CYP2C8 and antimalaria drug efficacy
Malaria is a major infectious disease. In the last 10 years it has killed more than 20 million people, mainly small children in Africa. The highly efficacious artemisinine combination therapy is being launched globally, constituting the main hope for fighting the disease. Amodiaquine is a main partn...
Autores principales: | Gil, JP, Gil Berglund, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117598/ https://www.ncbi.nlm.nih.gov/pubmed/17286541 http://dx.doi.org/10.2217/14622416.8.2.187 |
Ejemplares similares
-
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
por: Peter, Sijongesonke, et al.
Publicado: (2019) -
Towards the next generation of antimalaria combination therapies
por: Möhrle, Jörg J
Publicado: (2021) -
Plants as Sources of Natural and Recombinant Antimalaria Agents
por: Habibi, Peyman, et al.
Publicado: (2022) -
A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands
por: Li, Guoming, et al.
Publicado: (2023) -
Activities of Indian Antimalaria Units in World War II
por: Nair, C. P.
Publicado: (1949)